445680 — Curiox BioSystems Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩338bn
- KR₩324bn
- KR₩7bn
Annual cashflow statement for Curiox BioSystems Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | — | -14,525 | -11,498 | -10,042 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | — | 7,904 | 682 | -487 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -2,661 | 260 | -671 | 413 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -2,661 | -5,126 | -9,888 | -8,164 |
| Capital Expenditures | -188 | -261 | -841 | -212 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 2,293 | -8,050 | 5,574 | 3,110 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 2,105 | -8,311 | 4,734 | 2,898 |
| Financing Cash Flow Items | — | 13,087 | — | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 97.5 | 16,999 | -237 | 17,644 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -645 | 3,960 | -5,407 | 12,312 |